These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35383859)

  • 1. Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
    Lavoro A; Scalisi A; Candido S; Zanghì GN; Rizzo R; Gattuso G; Caruso G; Libra M; Falzone L
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35383859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.
    Badoer C; Garrec C; Goossens D; Ellison G; Mills J; Dzial M; El Housni H; Berwouts S; Concolino P; Guibert-Le Guevellou V; Delnatte C; Del Favero J; Capoluongo E; Bézieau S
    Oncotarget; 2016 Dec; 7(49):81357-81366. PubMed ID: 27793035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
    Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
    BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline.
    Koi Y; Watanabe A; Kawasaki A; Ideo S; Matsutani N; Miyashita K; Shioi S; Tokunaga E; Shimokawa M; Nakatsu Y; Kuraoka I; Oda S
    Environ Mol Mutagen; 2024 Jun; 65(5):179-186. PubMed ID: 38860553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System.
    de Oliveira Ferreira C; Carneiro VCG; Araujo Mariz C
    BMC Cancer; 2024 Apr; 24(1):499. PubMed ID: 38641594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.
    Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer onset across different
    Marchetti C; Ataseven B; Cassani C; Sassu CM; Congedo L; D'Indinosante M; Cappuccio S; Rhiem K; Hahnen E; Lucci Cordisco E; Arbustini E; Harter P; Minucci A; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2023 Feb; 33(2):257-262. PubMed ID: 36581488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso.
    Biancolella M; Ouédraogo NLM; Zongo N; Zohoncon TM; Testa B; Rizzacasa B; Latini A; Conte C; Compaore TR; Ouedraogo CMR; Traore SS; Simpore J; Novelli G
    Hum Genomics; 2021 Oct; 15(1):65. PubMed ID: 34717758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family.
    Yang X; Shang L; Yang L; Sun L; Tuo X; Ma S; Zhao L; Li X; Yang W
    Oncologist; 2024 Jun; 29(6):e837-e842. PubMed ID: 38159086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan.
    Ahmad H; Ali A; Ali R; Khalil AT; Khan I; Khan MM; Alorini M
    Neoplasia; 2024 May; 51():100989. PubMed ID: 38537553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological effects and clinical implications of BRCA mutations: where do we go from here?
    Stoppa-Lyonnet D
    Eur J Hum Genet; 2016 Sep; 24 Suppl 1(Suppl 1):S3-9. PubMed ID: 27514841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
    Boujemaa M; Hamdi Y; Mejri N; Romdhane L; Ghedira K; Bouaziz H; El Benna H; Labidi S; Dallali H; Jaidane O; Ben Nasr S; Haddaoui A; Rahal K; Abdelhak S; Boussen H; Boubaker MS
    PLoS One; 2021; 16(1):e0245362. PubMed ID: 33503040
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chao A; Lin YH; Yang LY; Wu RC; Chang WY; Chang PY; Chang SC; Lin CY; Huang HJ; Lin CT; Chou HH; Huang KG; Kuo WL; Chang TC; Lai CH
    J Gynecol Oncol; 2020 May; 31(3):e24. PubMed ID: 31912679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.
    Ponti G; De Angelis C; Ponti R; Pongetti L; Losi L; Sticchi A; Tomasi A; Ozben T
    Crit Rev Clin Lab Sci; 2023 Dec; 60(8):640-650. PubMed ID: 37455374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
    Walsh T; Lee MK; Casadei S; Thornton AM; Stray SM; Pennil C; Nord AS; Mandell JB; Swisher EM; King MC
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12629-33. PubMed ID: 20616022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.
    Thompson ER; Rowley SM; Sawyer S; kConfab ; Eccles DM; Trainer AH; Mitchell G; James PA; Campbell IG
    PLoS One; 2013; 8(1):e54772. PubMed ID: 23372765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
    Buzolin AL; Moreira CM; Sacramento PR; Oku AY; Fornari ARDS; Antonio DSM; Quaio CRDAC; Baratela WR; Mitne-Neto M
    Hum Genomics; 2017 Jun; 11(1):14. PubMed ID: 28651617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
    Venkitaraman AR
    DNA Repair (Amst); 2019 Sep; 81():102668. PubMed ID: 31337537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China.
    Fu K; Li Q; Wang J; Zhang M; Yan X; Li K; Song L; Zhong L; Ma Y; Chen J; Zeng J; Wang D; Shao D; Zhu S; Yin R
    Sci Rep; 2024 Mar; 14(1):6702. PubMed ID: 38509102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BRCA2 pathogenic variants in pediatric ganglioglioma: Case report and review of the literature.
    Gupta A; Lechpammer M; Brossier NM
    Childs Nerv Syst; 2024 May; 40(5):1609-1612. PubMed ID: 38168858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.